Amalgamated Bank’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,626
Closed -$9K 1738
2025
Q4
$9K Buy
2,626
+36
+1% +$221 ﹤0.01% 2450
2025
Q3
$23K Hold
2,590
﹤0.01% 2054
2025
Q2
$24K Hold
2,590
﹤0.01% 2040
2025
Q1
$22K Buy
2,590
+280
+12% +$2.64K ﹤0.01% 2019
2024
Q4
$25K Hold
2,310
﹤0.01% 2029
2024
Q3
$13K Hold
2,310
﹤0.01% 2311
2024
Q2
$10K Hold
2,310
﹤0.01% 2422
2024
Q1
$12K Sell
2,310
-7,573
-77% -$42.6K ﹤0.01% 2342
2023
Q4
$92K Sell
9,883
-687
-6% -$4.73K ﹤0.01% 2023
2023
Q3
$69K Hold
10,570
﹤0.01% 2120
2023
Q2
$86K Buy
10,570
+1,039
+11% +$8.9K ﹤0.01% 2117
2023
Q1
$82K Sell
9,531
-1,450
-13% -$14.5K ﹤0.01% 2125
2022
Q4
$102K Hold
10,981
﹤0.01% 2126
2022
Q3
$113K Buy
10,981
+277
+3% +$2.92K ﹤0.01% 2094
2022
Q2
$107K Sell
10,704
-219
-2% -$2.07K ﹤0.01% 2142
2022
Q1
$134K Sell
10,923
-750
-6% -$9.22K ﹤0.01% 2090
2021
Q4
$202K Buy
11,673
+238
+2% +$4.52K ﹤0.01% 1972
2021
Q3
$205K Sell
11,435
-283
-2% -$5.63K ﹤0.01% 1987
2021
Q2
$268K Buy
+11,718
New +$174K ﹤0.01% 1932

Other funds holding AVXL

Amalgamated Bank's AVXL Position: Q1 2026 in Review

Amalgamated Bank sold out of Anavex Life Sciences (AVXL) in Q1 2026, closing a stake of 2,626 shares — an estimated $9K sold.

Amalgamated Bank first reported a position in AVXL in Q2 2021 and held it in 19 quarters. The position peaked at $268K in Q2 2021. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Amalgamated Bank reported no remaining Anavex Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 2,626 Anavex Life Sciences shares in Q1 2026, an estimated $9K.
  • Amalgamated Bank first reported a position in Anavex Life Sciences in Q2 2021 and held it in 19 quarters.
  • Amalgamated Bank's Anavex Life Sciences position peaked at $268K in Q2 2021.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.